PREventive Care Infrastructure Based On Ubiquitous Sensing (PRECIOUS). VHIR Pilot.

NCT02818790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-22

No results posted yet for this study

Summary

The goal of the MI field test is to assess users' overall satisfaction, usability and acceptability of the PRECIOUS system, and to explore if MI in combination with gamification principles is a feasible solution to foster adherence to PRECIOUS system. Moreover, it is pursued to trigger behavior change and build up motivation to maintain sustained change towards healthy lifestyles. The field test at University Hospital Vall d'Hebron will be carried out with morbidly obese pre-diabetic patients. This pilot test will serve to explore users' acceptance of PRECIOUS system in an early stage of its development. Considering that this is a pilot test, feedback and outcomes obtained will serve to refine and adjust PRECIOUS system concept and architecture.

Conditions

Interventions

BEHAVIORAL

Intervention 1

Bodyguard + Precious App. Short onsite training session on how to use the system.

BEHAVIORAL

Intervention 2

Bodyguard + Precious App + Motivational Interviewing. Face to face counseling session followed by a short onsite training session on how to use the system.

Sponsors & Collaborators

  • Aalto University

    collaborator OTHER
  • University of Helsinki

    collaborator OTHER
  • Firstbeat Technologies Ltd.

    collaborator INDUSTRY
  • University of Vienna

    collaborator OTHER
  • Telecom Bretagne

    collaborator UNKNOWN
  • Campden BRI

    collaborator UNKNOWN
  • EuroFIR

    collaborator UNKNOWN
  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Jose Costa Requena, PhD · Aalto University

  • Pilar Lusilla Palacios, PhD, MD · Hospital Universitari Vall d'Hebron - Fundació Institut de Recerca Vall d'Hebron. Department of Psychiatry

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-07-31
Completion
2016-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02818790 on ClinicalTrials.gov